Moderna Stock

Moderna ROIC

The Return on Invested Capital (ROIC) of Moderna (MRNA) as of Aug 6, 2026 is -30.48 %. In the previous year, Return on Invested Capital (ROIC) was -32.48 % — a change of -6.18% (higher).

ROIC

-30.48 %

YoY

-6.18%

Last updated:

Return on Invested Capital (ROIC) of Moderna is 2026 -30.48 % . Return on Invested Capital (ROIC) of Moderna was 2025 -32.48 % . It decreases by -6.18% higher compared to the previous year.
Access this data via the Eulerpool API

Moderna Stock analysis

What does Moderna do? Moderna Inc is a biotechnology company from the USA that specializes in the development of therapies and vaccines based on mRNA technology. The company was founded in 2010 by a group of researchers led by Noubar Afeyan and is headquartered in Cambridge, Massachusetts. Moderna is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Moderna stock

Return on Invested Capital (ROIC) of Moderna is -30.48 % in 2026.

Return on Invested Capital (ROIC) of Moderna changed from -32.48 % to -30.48 %, representing a -6.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Invested Capital (ROIC) Moderna since 2006 – with annual values, charts, and detailed analysis.

ROIC measures how effectively a company uses its invested capital to generate profits. A ROIC above the cost of capital creates shareholder value.

ROIC = NOPAT / Invested Capital

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Invested Capital (ROIC)'s Moderna with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Invested Capital (ROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Invested Capital (ROIC).

Access this data via the Eulerpool API

Profitability — Moderna

All Key Metrics — Moderna